Hepatitis C virus (HCV) core has a pleiotropic effect on various promoters. In this study, we found that the expression of nucleolar phosphoprotein B23 was enhanced in HCV core-expressing cells and, moreover, HCV core interacts directly with the C-terminal end of B23. Using sucrose gradient centrifugation analysis and immunoprecipitation assays, HCV core was found in a large complex containing B23 and its interacting partner transcription factor YY1. Both B23 and HCV core associated with YY1 in the central GA/GK-rich and C-terminal zinc finger domain. These physical interactions between core, B23, and YY1 led to ternary complex formation that was bound to the YY1 response element. In a transient cotransfection experiment, relief of the transsuppression activity of YY1 on the YY1-response elementdriven reporter by core and B23 was found. This is also true when examining the effects of these three constructs on the B23 promoter-driven reporter. Additionally, chromatin immunoprecipitation assays indicated that a transcriptional activation complex consisting of core, together with B23, p300, and YY1, was recruited to the YY1 response element of B23 promoter, and this probably occurred through complex formation between core and these three cellular transcription regulators. This is different from the situation in the absence of core, where YY1 and histone deacetylase 1, but not B23 and p300, were associated on the YY1 element as the transcription repression complex. Together, our results indicate that HCV core can recruit B23 and p300 to relieve the repression effect of YY1 on B23 promoter activity, a property that requires the intrinsic histone acetyltransferase activity of p300. Thus, because these three core-associated cellular transcription regulators have a multitude of cellular interacting proteins and are involved in a versatility of cellular processes, the complex formation described here may partially account for the pleiotropic effects of core protein on gene expression and cellular function in HCV-infected cells.
Introduction
Hepatitis C virus (HCV) is a major cause of posttransfusion non-A, non-B hepatitis Kuo et al., 1989) . Its infection often leads to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (Bruix et al., 1989; Saito et al., 1990) . The HCV RNA genome encodes a polyprotein of about 3010 amino acids that is processed by host and viral proteases into core, envelope, and several nonstructural proteins (reviewed in Reed and Rice, 2000) . Among these HCV viral proteins, core has received the most attention. Apart from functioning as a viral nucleocapsid, it also affects a whole array of host cell functions including DNA damage and repair (Machida et al., 2004a, b; van Pelt et al., 2004) , apoptosis, signal transduction, and transcriptional regulation (reviewed in Tellinghuisen and Rice, 2002; Watashi and Shimotohno, 2003) . These are attributable, at least in part, to its ability to modulate the cellular transcriptional machinery, and to interact with a wide spectrum of cellular factors (reviewed in Tellinghuisen and Rice, 2002) . Moreover, HCV core is capable of transforming rodent fibroblasts in cooperation with Ras (Chang et al., 1998) and is able to cause the development of hepatocellular carcinoma at the late stage of the transgenic mice (Moriya et al., 1998) . Together, several lines of evidence suggest the direct involvement of HCV core protein in the HCVassociated pathogenesis.
B23, also known as nucleophosmin (NPM), is a major nucleolar phosphoprotein that functions in ribosome biogenesis and transport (reviewed in Okuda, 2002) . Expression of this gene is higher in tumorigenic and proliferative cells than in normal cells. It possesses both DNA-and RNA-binding ability, and is capable of shuttling between the nucleolus and cytoplasm (reviewed in Okuda, 2002) . Moreover, it binds to numerous cellular factors including YY1 (Inouye and Seto, 1994) , Rb (Takemura et al., 2002) , IRF-1 (Kondo et al., 1997) , and p53 (Colombo et al., 2002; Kurki et al., 2004) . In view of its ability to inhibit drug-or UV-induced cell death and growth arrest, B23 has been suggested to be a positive regulator of cell proliferation . Additionally, recent studies indicate that B23 is a natural negative regulator for p53 that sets a threshold for p53 response to UV radiation (Maiguel et al., 2004) . All this suggests that B23 plays an important role in the regulation of cellular proliferation, differentiation, and apoptosis.
YY1 is a ubiquitous zinc finger transcription factor that activates or represses the transcription of many cellular and viral promoters (reviewed in Shi et al., 1997; Thomas and Seto, 1999) . The molecular mechanism by which YY1 modulates transcription is mainly through interaction with transcriptional regulatory partners, such as TBP, TFIIB, TAFII55, E1A, Sp1, ATF/CREB, c-Myc, RNA polymerase II large subunit, and B23. Additionally, YY1 also recruits chromatin-modifying enzymes, including histone acetyltransferases (HATs, e.g. CBP and p300) and histone deacetylases (HDACs) (reviewed in Thomas and Seto, 1999) . In addition to transcriptional regulation, YY1 also plays a critical role in development and cell cycle regulation (Donohoe et al., 1999; Petkova et al., 2001; Palko et al., 2004) . Recent studies also indicate that YY1 is a negative regulator for p53 (Sui et al., 2004; Gronroos et al., 2004) and is a specific target of caspases during apoptosis (Krippner-Heidenreich et al., 2005) .
In this study, we demonstrate that the mRNA and the protein levels of B23 were elevated in HCV coreproducing cell lines. Furthermore, the core protein can interact with B23 and transcriptional factor YY1, and together they form a large complex. This ternary complex retains the DNA-binding ability to YY1 response element. Moreover, using a chromatin immunoprecipitation (ChIP) assay in conjunction with a reporter assay, our results indicate that the transrepression activity of YY1 on the YY1 response element of B23 promoter was relieved by the HCV core due to the recruitment of B23 and p300 as part of an activation complex mediated through complex formation between core, p300, YY1, and B23. Interestingly, this activation of the B23 promoter is highly dependent on the HAT activity of p300. Since all these three core-interacting partners B23, YY1, and p300 are potent cell growth regulators (reviewed in Shi et al., 1997; Goodman and Smolik, 2000; Okuda, 2002) , their interaction with HCV core suggests a role for the core protein in cell growth control. All these properties may be able to explain the plethoric effects on gene expression and the ability of HCV core protein to establish cellular proliferation.
Results

HCV core enhances the expression of nucleolar phosphoprotein B23
In a search for potential cellular genes modulated by the HCV core using the mRNA differential display technique (Liang and Pardee, 1992 ) (GenHunter Co.), we identified nucleolar phosphoprotein B23 as one of the upregulated genes. Quantitative real-time PCR analysis confirmed the upregulation (1.3-2.2-fold increase) of the B23 transcript level in several HCV core-producing (HuH-7/C190) stable cell lines (clone #6, pool, #3) (lanes 2-4) and that this occurred in core expression level-dependent manner (Figure 1a) . When compared to their parental cells (lane 1), an increase ranging from 1.9-2.6-fold (lanes 2-4) in B23 protein level as revealed by Western blot analysis was also observed in these HuH-7/C190 cells using a-tubulin as a loading control (Figure 1b) . Therefore, it appears that HCV core upregulates the expression of B23 in HuH-7 cells.
HCV core interacts with B23
Since B23 can shuttle between the cytoplasm and nucleus (Borer et al., 1989) and HCV core also localizes in both the cytoplasm and nucleus (Barba et al., 1997; Chen et al., 2003) , we examined the possibility of an interaction between these two proteins. As shown in Figure 2a , B23 and FLAG-tagged HCV core (FLAG core) was coimmunoprecipitated by the anti-FLAG antibody in HuH-7 cells transiently transfected with FLAG-core expression construct (lane 4). We also investigated the possibility of colocalization of these two proteins. Using indirect immunofluorescence microscopy, our results indicated that core protein in HuH-7/C190 pool cells (designated as HuH-7/C190 thereafter) colocalized with the endogenous B23 in nucleoli (Figure 2b ). Thus, apart from the modulation of gene expression, the HCV core also associates with cellular B23 in vivo.
Next, we examined whether the association of core protein with cellular B23 is through a direct proteinprotein interaction. To this end, the GST-B23 fusion protein was used for pull-down binding analysis of Figure 1 HCV core enhances the expression of nucleolar phosphoprotein B23. (a) The B23 transcript levels in HCV coreproducing stable cell lines (HuH-7/C190 #6, HuH-7/C190 pool, and HuH-7/C190 #3) and their control cells (HuH-7) were measured by quantitative real-time RT-PCR. The data were compared, after being normalized to internal control GAPDH. The PCR products were analysed on a 2% agarose gel, followed by ethidium bromide staining. (b) The cellular B23, a-tubulin, and HCV core were detected by immunoblotting (WB) with anti-B23, anti-a-tubulin (C-20, Santa Cruz), and rabbit anti-HCV core antibodies, and their intensities were quantitated by Densitometert SI and normalized to the internal control a-tubulin. The results were calibrated to the expression levels of B23 in HuH-7 cells.
in vitro translated 35 S-labeled HCV core proteins. As shown in Figure 2c , all of the in vitro translated T7-tagged HCV core variants harboring the N-terminal 101, 122, or 195 amino-acid residues (abbreviated as C101, C122, or C195) were precipitated by purified GST-B23 fusion protein (lanes 9-11), but not by GST protein (lanes 6-8). Additionally, GST/HCV-core fusion proteins harboring a N-terminal fragment larger than 101 amino-acid residues (GST/HCVc101, GST/ HCVc122, and GST/HCVc195) ( Figure 2d , lanes 9-11), but not the N-terminal 50 amino-acid residues (GST/ HCVc50) and GST (lanes 7 and 8), could pull down the in vitro translated B23, suggesting that the region between residues 51 and 101 in HCV core is important to in vitro binding with B23.
HCV core forms a large complex with the nuclear B23 and its interacting protein YY1 in vivo and in vitro Since cellular B23 is capable of interacting with various cellular factors, it would be interesting to know whether the HCV core could perturb the interaction of B23 with other cellular factors. The in vivo molecular status of the complex formation between these two nuclear proteins in the nuclear extracts of HCV core-expressing HuH-7/ C190 cells was therefore examined by sucrose gradient centrifugation. As shown in Figure 3a , nuclear B23 in the presence or absence of the HCV core was mainly detected in two peaks at fractions 6-11 (first peak, maximum at fractions 7-9) and fractions 13-18 (second peak, maximum at fractions 14-16). When comparing their sedimentation position with standard proteins, we found that the first peak sedimented at a position larger than 232 kDa (catalase, fraction 7), and the second peak was much larger than 669 kDa (thyroglobulin, fraction 10). Given that nuclear B23 (38 kDa in size) is largely in the hexameric form with a molecular mass of 230-255 kDa (Yung and Chan, 1987) , this result suggests that the nuclear B23 protein is either assembled into an oligomer or associated with other cellular components. Although there was a slight increase in the sizes of B23 complexes found in the core-producing cells compared 3) or pcDNA-SRa-FLAG core (lanes 2 and 4). Nuclear extracts prepared from the transfected cells were immunoprecipitated by anti-FLAG M2 agarose affinity gel and immunoprecipitates were analysed by immunoblotting with anti-B23 or anti-core antibody. (b) Colocalization of HCV core and B23 in the nucleolus. HuH-7 and HuH-7/C190 cells were fixed and reacted with mouse anti-B23 (Zymed) and rabbit anti-HCV core antibodies. B23 was detected by rhodamine-conjugated anti-mouse IgG (red), and HCV core was detected by FITC-conjugated anti-rabbit IgG (green) under confocal microscopy. The yellow color in the merged image indicated the colocalization of HCV core and B23. (c) In vitro binding assay of GST-B23 and HCV core. GlutathioneSepharose 4B beads bound to GST (lane 1) or GST-B23 (lane 2) were incubated with in vitro translated T7-tagged HCV core variants (C101, C122, C195) (lanes 3-5). The beads were then washed, and proteins on the beads were analysed by SDS-PAGE and autoradiography (lanes 6-11). (d) In vitro binding assay of GST/HCV-core fusion proteins and B23. Glutathione-Sepharose 4B beads bound to GST (lane 1), GST/HCVc50 (lane 2), GST/HCVc101 (lane 3), GST/HCVc122 (lane 4), or GST/HCVc195 (lane 5) were incubated with the in vitro translated B23. The beads were then washed, and proteins on the beads were analysed by SDS-PAGE and stained with Coomassie brilliant blue (lanes 1-5) and followed by autoradiography (lanes 6-11). Input: 20% of 35 S-labeled B23 (Lane 6).
to those in their parental cells, the majority of the core protein sedimented at the same position as both B23 complexes (fractions 7-9 and fractions 12-17). Therefore, it appears that the HCV core associates with nuclear B23 within a large complex with a size greater than 230 kDa.
The possibility that the complex association of B23 and core protein involved the interaction of B23 with other cellular interacting proteins was further explored by examination of the sedimentation profile of the B23-interacting transcription factor YY1 (Inouye and Seto, 1994) in these sucrose gradients. Again, similar to the HCV core, when detected by immunoblot, apart from a smaller YY1-containing complex, which appeared at fractions 8-12 (maximum at fractions 10-11), at least half the population of YY1 in HuH-7/C190 cells cosedimented with the high molecular weight form of B23 and core protein at fractions 13-18 (maximum at fractions 15-16) (Figure 3a, . This sedimentation behavior of YY1 in core-expressing cells is rather different from that in control cells, because in HuH-7 cells YY1 was distributed broadly from fractions 8-18 and peaked at fractions 14-15. Coimmunoprecipitation on the sucrose gradient fractions of HuH-7/C190 cells with anti-YY1 antibody in combination with the Western blotting analysis suggested that YY1 associated with B23 but not core protein in the smaller complex at fractions 7-9 of the gradient, while it probably formed a complex with both B23 and core protein in the larger complex at fractions 14-16 (Figure 3b, lanes 3 and 4) . Interestingly, the YY1-associated chromatin remodeling factor p300 was also present in both B23-containing complexes in HuH-7/C190 cells (Figure 3b, lanes 3 and  4) . Notably, a similar coimmunoprecipitation experiment on the corresponding sucrose gradient fractions of HuH-7 cells indicated that YY1 associated with B23 and p300 in the large complex at fractions 14-16 ( Figure 3b , lane 2), but was not associated with the smaller B23 complex at fractions 7-9 ( Figure 3b , lane 1) of the gradient. This property is rather different from that of HuH-7/C190 cells (compare lanes 1 and 2 with lanes 3 and 4 in Figure 3b ). Additionally, in the pull-down assay by GST/HCVc195 and GST-B23 fusion proteins using the cell lysates of HuH-7 and HuH-7/C190 cells, the cellular YY1 and B23 could interact with HCV core (Figure 3c ) and also cellular YY1 and HCV core in HuH-7/C190 cell lysates could be pulled down by the B23 as well (Figure 3d ). Taken together, our results indicate that the nuclear HCV core associates with B23 and its interacting protein YY1 to form large nuclear complexes in core-producing HuH-7 cells. Mapping the interaction regions between HCV core, B23, and YY1 Since HCV core, B23, and YY1 would seem to form a ternary complex in the nucleus, it would be interesting to know the interaction region between HCV core, B23, and YY1. As shown in Figure 4a , GST/HCV-core fusion proteins larger than the N-terminal 101 aminoacid residues, but not the N-terminal 50 amino-acid residues or GST, could interact with in vitro translated (lanes 1-5) and cellular YY1 (lanes 6-10). Thus, this reveals that the N-terminal residues 51-101 of core protein are critical for interaction with YY1. It should also be noted that this same region of the HCV core is important for interaction with B23 (see Figure 2c) .
We next dissected the regions essential for interaction of HCV core or YY1 within B23. To this end, we analysed the binding of the GST/HCVc195 or GST-YY1 fusion proteins to various lengths of in vitro translated B23 ( Figure 4b ). As shown in Figure 4c , only the in vitro translated full-length (294 amino-acid residues) of B23 (B23(1-294)) could interact with the GST/HCVc195 (lane 10), but not C-terminal truncated B23 variants harboring the N-terminal 127, 144, 190, and 285 amino-acid residues (B23(1-127), B23(1-144), B23(1-190), B23(1-285)) (lanes 6-9). Thus, the integrity of the C-terminal nine amino-acid residues of B23 is necessary for binding with the HCV core. On the other hand, in vitro translated B23 variants larger than the N-terminal 144 amino-acid residues (B23(1-144), B23(1-190), B23(1-285), and B23(1-294)) (lanes 12-15), but not C-terminal truncated B23 variants B23 (1-127) (lane 11), could be pulled down by GST-YY1, suggesting that N-terminal residues 128-144 of B23 are important for binding with YY1.
We also constructed a series of GST-YY1 truncated mutants to dissect the interaction regions of HCV core or B23 with YY1 by GST pull-down assay. As shown in Figure 4d , in addition to interact with full-length YY1 fusion protein (GST-YY1) (lane 10), in vitro translated HCV core or B23 could interact with GST-YY1/155-198, GST-YY1/1-198, GST-YY1/1-295, GST-YY1/1-325, GST-YY1/1-352, and GST-YY1/296-414 (lanes 2, 6-9), but not with other truncated GSY-YY1 variants (GST-YY1/199-295, GST-YY1/1-80, and GST-YY1/ 1-154) (lanes 3-5). Thus, the results (summarized in Figure 4e ) reveal that both B23 and core protein associate with YY1 in the region of amino-acid residues 155-198 (central GA/GK-rich domain) and 296-414 (C-terminal zinc finger domain). It should be noted that these HCV core-or B23-interacting regions are the DNA-binding domain or/and transrepression domains of YY1, and are also important for association with other cellular factors (reviewed in Thomas and Seto, 1999) .
HCV core, B23, and YY1 form a ternary complex on the YY1 response element Since the transcription factor YY1 can bind to its response element at the consensus sequence GCCCATCTTG (Hyde-DeRuyscher et al., 1995), the association of HCV core and B23 with the zinc-finger domain of YY1 probably may affect the DNA-binding activity of YY1. To test this possibility, streptavidin-biotin agarose affinity chromatography was used to examine the DNA-binding activity of YY1 in the absence or presence of core protein. As shown in Figure 5a , in HuH-7 cells, only YY1 but not B23 could bind to a biotinylated YY1 response element (lane 2). However, in HuH-7/C190 cells, in addition to YY1, both HCV core and B23 were also retained by the biotinylated YY1 response element ( Figure 5a , lane 4; Figure 5b , lane 4). Since in the control experiment there was no detectable or reduced signal for YY1, B23, or core protein on the nonbiotinylated ( Figure 5a , lanes 1 and 3) or mutated YY1 element ( Figure 5b , lanes 1 and 3), the binding of HCV core, B23, and YY1 on this biotinylated YY1 element is sequence-specific and probably mediated through complex formation with YY1. Therefore, our results indicate that the complex formation between HCV core, B23, and YY1 does not disrupt the DNA-binding activity of YY1.
HCV core and B23 modulate the trans-action activity of YY1 As noted previously, both B23 and HCV core associate with YY1 in the regions of amino-acid residues 155-198 (central GA/GK-rich domain) and 296-414 (C-terminal zinc finger domain), which overlap the transrepression domains of YY1 (reviewed in Shi et al., 1997) . It would thus be interesting to investigate whether the trans-action activity of YY1 is affected by these two interacting proteins. To test this possibility, reporter assays were performed and the effects of core and/or B23 on the trans-action ability of YY1 were examined. HuH-7 cells were transiently cotransfected with effector plasmids expressing GAL4-YY1, core protein, or B23, either alone or in combination, and reporter plasmid pFR-Luc, which harbors five copies of GAL4 DNAbinding site upstream of a minimal promoter (Stratagene). As shown in Figure 6a , introducing the expression construct containing core protein or GAL4-YY1 into HuH-7 cells leads to an about 1.5-2-fold enhancement of the reporter plasmid activity (compare lanes 2 and 3 with lane 1), while overexpression of B23 had no effect (lane 4). Nevertheless, cotransfecting similar amounts of core and GAL4-YY1 expression constructs provoked an enhancement (three-fold) of the reporter plasmid activity (lane 5), while cotransfecting of all these three constructs together further potentiated the reporter plasmid activity to about six-fold (lane 8).
We next examined the effect of HCV core, B23, and YY1 on the activity of the reporter plasmid pYY1-RELuc, which harbors two copies of the YY1 response element upstream of thymidine kinase (TK) promoter (À105B þ 51). As shown in Figure 6b , in HuH-7 cells, transient transfection of the core protein had essentially no effect on the reporter plasmid activity (lane 2), while YY1 suppressed 50% of the reporter activity (lane 3) and B23 had a slightly inhibitory effect (lane 4). Nevertheless, cotransfection with expression constructs Figure 4 Mapping the interaction regions between HCV core, B23, and YY1. (a) In vitro binding assay of GST/HCV-core fusion proteins with YY1. Glutathione-Sepharose 4B beads bound to GST (lanes 1 and 6), GST/HCVc50 (lanes 2 and 7), GST/HCVc101 (lanes 3 and 8), GST/HCVc122 (lanes 4 and 9), or GST/HCVc195 (lanes 5 and 10) were incubated with the in vitro translated YY1 or nuclear extracts of HuH-7 cells. The beads were then washed, and proteins on the beads were analysed by SDS-PAGE and followed by autoradiography (lanes 1-5) or immunoblotting with anti-YY1 antibody (lanes 6-10). of core and B23 resulted in an enhancement (2.1-fold) of the reporter plasmid activity (lane 6) and cotransfection with these three constructs together enhanced the reporter plasmid activity by about 3.7-fold (lane 8). Similar reporter assays were also conducted on the reporter plasmid pTK(À105B þ 51)-Luc without the YY1 element (see Supplementary Figure 1 ) and results showed that the suppression effect of YY1, and the activation effects of core with B23, or core together with YY1 and B23 were lost. These results suggest that the coexpression of HCV core, YY1, and B23 activate YY1 element-containing reporter activity and this activation is YY1 response element-dependent. Thus, it appears that the formation of a ternary complex between these three proteins can relieve the trans-repression ability of YY1.
HCV core, YY1, and B23 coactivate B23 promoter through YY1 response element When considering that a YY1 response element resides within the 5 0 enhancer region of the B23 gene (CGCC ATTTTG, nt À361 to À352 related to the transcription start site) (Chan et al., 1997) and that both mRNA and protein levels of B23 were enhanced by HCV core protein (see Figure 1) , it is pertinent to investigate whether this enhancement was achieved by cooperation between these three proteins (HCV core, YY1, and B23) through the YY1 response element. To this end, we Figure 5 HCV core, B23, and YY1 form a ternary complex on the YY1 response element. (a) The nuclear extracts of HuH-7 or HuH-7/C190 were incubated with annealed WT form of biotinylated YY1 probe and streptavidin-agarose beads (lanes 2 and 4). For the control experiment, the nuclear extracts were incubated with streptavidin-agarose beads in the absence of YY1 probe (lanes 1 and 3). After incubation, the resins were washed and the bound fractions were analysed by immunoblotting with antibody against HCV core, YY1, or B23. (b) Experiments similar to those described in panel (a) were performed, except that both WT (lanes 2 and 4) and a mutant-type (mt) (lanes 1 and 3) form of biotinylated YY1 probe were used. examined the effect of these proteins on reporter plasmid pB23P-Luc activity when the plasmid contains a luciferase gene driven by the B23 promoter (nt À744 to þ 35, related to the transcription start site). As shown in Figure 6c , the introduction of constructs producing core or B23 alone seemed to have no effect (compare lanes 2 and 4 with lane 1), whereas introduction of constructs producing YY1 alone suppressed reporter plasmid activity by about 50% (lane 3). Thus, YY1 could suppress B23 promoter activity. Cotransfection with expression constructs of core protein and YY1 slightly relieved the suppression effect of YY1 (about 75% of the control cells; lane 5). Surprisingly, cotransfection with all three constructs together was able to counteract the suppression and gave rise to an about four-fold activation compared with the YY1-transfected cells (compare lane 8 with lane 3). Thus, the core-mediated enhanced expression of B23 was achieved by cooperation between HCV core, YY1, and B23. Also noted, the YY1 response element on B23 promoter was required for this enhancement effect, because the activities of a reporter plasmid pB23Pmt-Luc harboring a mutated YY1 element in cells cotransfected with effector plasmids for core, YY1, and B23, either alone or in combination, were essentially not affected (see Supplementary Figure 2 ).
HCV core, YY1, B23, and p300 bind to YY1 response element on the B23 promoter in vivo To investigate in vivo complex formation between HCV core, B23, YY1, and other cellular factors on the B23 promoter, we examined the recruitment of these factors to the B23 promoter in the absence or presence of HCV core using the ChIP assay. The presence of the specific promoter region (nt À491 to À247) of the B23 promoter in the immunoprecipitates, which was analysed by PCR using B23 promoter-specific primers spanning YY1 response element, represents protein occupancy on the chromatin in vivo. As shown in Figure 7 , occupancy by core and B23 of the B23 promoter around YY1 response element was only observed in the presence of core protein (lanes 13 and 15), while YY1 was present regardless of the core protein status (lanes 5 and 14). These results suggest that core and B23 were recruited to the YY1 element within the B23 promoter by interacting with YY1. Since YY1 suppressed, whereas coexpression of core, B23, and YY1 activated the activity of B23 promoter (Figure 6c ), these effects might result from differential recruitment of other cellular factors when the core protein is present. To test this possibility, we also examined the occupancy by coactivators (p300 and CBP) and corepressor (HDAC1) of the B23 promoter, since YY1 can interact with chromatin remodeling factors such as p300, CBP, or HDACs. The presence of HDAC1 (Figure 7 , lanes 7 and 16) or the absence of CBP (Figure 9 , lanes 9 and 18) on this transcriptional complex was not affected by whether core protein was present or absent. However, in the presence of core protein p300 was recruited to B23 promoter ( Figure 7 , lane 17), and this recruitment is likely to contribute to B23 promoter activation by cooperation with HCV core, B23, and YY1.
HCV core interacts with p300, but not CBP, HDAC1, HDAC2, and HDAC3 As noted, the presence of HCV core changes the composition of transcription complexes on YY1 response element of B23 promoter (see Figure 7) . This, presumably, is due to the recruitment of these coactivators or corepressors via the HCV core. We first examined interaction between HCV core and p300 or CBP. As shown in Figure 8a , cellular p300 but not CBP in HuH-7 nuclear extracts could be pulled down by GST/HCVc195 and, moreover, HCV core in HuH-7/ C190 cells could be coimmunoprecipitated by anti-p300 antiserum (Figure 8b ). These results indicate that HCV core physically interacts with p300, which is consistent with a recent result by Gomez-Gonzalo et al. (2004) . The interaction of HCV core and various HDACs was also examined. As shown in Figure 8c , there was no indication that HCV core interacted with HDAC1, HDAC2, or HDAC3 from a GST-HDACs pull-down analysis of in vitro translated HCV core (lanes 3-5), although the GST-YY1 assay did show a positive result (lane 2). All together, our results suggest that the recruitment of p300 and B23, but not HDAC1, to the YY1 element of B23 promoter is likely to be mediated by HCV core. p300 in cooperation with HCV core, YY1, and B23 potentiate the activation of B23 promoter Taking into account the fact that p300 was recruited to the YY1 response element of B23 promoter via the HCV core, it would be interesting to know whether p300 also Figure 7 HCV core, B23, YY1, and p300 form a complex on B23 promoter in vivo. A ChIP assay in HuH-7 or HuH-7/C190 cells was performed as described (see Materials and methods). Cell lysates were subjected to immunoprecipitation with antibodies as indicated, and the immunocomplexes were then precipitated by the addition of protein G-Sepharose beads. After intensive washing, the bound DNA-protein complexes were eluted, the crosslinking reversed, and the DNA fragments were then purified. PCR reactions were performed with B23 promoter-specific primers, and PCR products were analysed on a 1.8% agarose gel.
contributes to the activation of B23 promoter. To examine this, a cotransfection experiment similar to Figure 6c was carried out using the B23 promoter-driven reporter, except that the expression construct p300 was also included in the cotransfection experiments. Essentially the same results as in Figure 6c were obtained when HCV core, YY1, or B23 were introduced either alone or in combination (compare lanes 1-4, 6, 7, 9, and 12 in Figure 9 with lanes 1-8 in Figure 6c , respectively). However, introducing p300 alone activated the reporter plasmid activity by about 1.8-fold (compare lane 5 with lane 1) and cotransfection with expression constructs of core and p300 had a synergistic effect, resulting in about 3.7-fold activation (lane 8) compared with the control cells (lane 1). Moreover, introducing p300 potentiated the reporter activation achieved by core, YY1, and B23 from 2.2-to 6.2-fold (compare lane 12 with lane 16). However, transfection with the coactivator p300 construct may result in a general activation of gene expression, which argues against the hypothesis that the core-mediated activation of B23 gene was through protein-protein interaction. To exclude this possibility, we determined the relative protein amounts of core, YY1, B23, or p300 in the transient transfected cells using actin as an internal control ( Figure 9 , lower panel). Our results indicated that there was no significant change in protein expression levels of core, B23, or YY1 when cells were cotransfected with coactivator p300. Thus, the core-mediated upregulation of B23 gene expression was achieved by cooperation between HCV core, YY1, and B23, and the coremediated recruitment of coactivator p300. Similar reporter assays were also conducted on the reporter plasmid pB23Pmt-Luc harboring a mutated YY1 element (see Supplementary Figure 3) . Our results clearly indicate that the YY1 response element of B23 Figure 9 p300 potentiates the activation of B23 promoter in cooperation with HCV core, YY1, and B23. HuH-7 cells were cotransfected by Lipofectamine Plust reagent (GibcoBRL) with reporter plasmid pB23P-Luc (0.25 mg), pSRa/HCVc195 (or pSRa, 0.25 mg), pCMV-YY1 (or pCMV2, 0.5 mg), pCR3-FLAG-B23 (or pCR3, 1 mg), or pSK-p300-myc (or vector plasmid, 1 mg) as indicated. After 48 h post-transfection, the luciferase activities in the transfected cell lysates were assayed. The results are presented as the means7s.d. for at least three separate experiments. Cell lysates were subjected to SDS-PAGE and processed for Western blotting by using anti-HCV core, anti-YY1, anti-B23, anti-p300, or anti-actin (C-19, Santa Cruz) antibodies.
promoter is essential for B23 promoter activation achieved by YY1, HCV core, B23, and p300. One interesting possibility is that the intrinsic HAT activity of p300 may be essential for the activation of B23 promoter. To this end, we examined the transactivation effect of an acetyltransferase-negative mutant construct of p300 (D1399Y) (Ito et al., 2001) in these cotransfection experiments (see Supplementary Figure  4) . Unlike the wild-type (WT) p300, this mutant p300 (D1399Y) alone was unable to activate B23 promoter and, moreover, it also lost the synergistic effect described earlier when cotransfected with core, B23, and YY1. These results indicate that the intrinsic HAT activity of p300 plays an important role in enhancement of B23 promoter activity.
We also examined the trans-activation effect of a mutant expression construct of core protein (core (1-50)) (refer to the 50 N-terminal amino acids), which lacks interaction with both B23 and YY1 (see Figures 2d  and 4a ). Since the synergistic trans-activation effect was not detectable in this set of cotransfection experiments (see Supplementary Figure 5 ), this strongly suggests that the physical interaction between these three proteins (core, B23, and YY1) was critical for coactivator p300 to potentiate the activation of B23 promoter.
Discussion
HCV core facilitates the formation of the transcriptional activation complex on B23 promoter In this study, we have identified the nucleolar phosphoprotein B23 as one of potential cellular genes modulated by the HCV core protein. We demonstrated that the HCV core has several effects on B23, including upregulation of its gene expression (see Figure 1) and the formation of a large nuclear complex consisting of HCV core, B23, and at least one of B23-interacting transcriptional factor YY1 (see Figure 3a) . Through protein-protein interactions (see Figures 2-4) , these three proteins form complexes on the YY1 response element (see Figure 5) , which results in a relief of the suppression effect of YY1 on YY1 response elementcontaining reporters systems, specifically a B23 promoter-driven one (see Figures 6) . Additionally, another HCV core-interacting protein p300 (see Figure 8) is also recruited to the YY1 response element of B23 promoter (see Figure 7 ), which cooperates with HCV core and helps B23 and YY1 to induce B23 promoter activation (see Figure 9 ). In accordance with these findings, we conclude that through physical interactions between HCV core with B23, YY1, and coactivator p300, the core orchestrates the formation of a large transcriptional activation complex consisting at least these four proteins on the YY1 response element of B23 promoter, and this converts the suppression effect of YY1 on B23 gene expression to enhancement. Notably, this core-mediated enhancement of B23 gene expression occurs to a similar extent as that induced by hepatitis delta antigen (Huang et al., 2001) or damaged DNA reported previously. Presumably, this low level (1.5-3-fold) of induction fold on B23 gene expression is likely due to its high abundance in the nucleolus, a property noted previously (reviewed in Okuda, 2002) .
There is a precedent for a viral protein converting YY1 from a negative to a positive regulator. There is a case where the adenovirus E1A protein switches the repression effect of YY1 to a positive effect in adenoassociated virus (AAV) P5 promoter transcription, without affecting DNA binding of YY1 (Shi et al., 1991) . Relief of YY1-induced transcriptional repression by E1A may involve direct interaction between E1A and YY1, as well as interaction between the E1A-associated protein p300 and YY1 Lewis et al., 1995) . This is similar to the recruitment of the coactivator p300 to the B23 promoter in the presence of HCV core protein (Figure 7 ). YY1 interacts with p300 (Thomas and Seto, 1999) ; thus, the recruitment of p300 to B23 promoter may be mediated by YY1. However, because p300 is absent from the B23 promoter when there is no HCV core present (Figure 7 ), this would seem to not be the case. Our work also indicates that p300 potentiates the activity of B23 promoter through cooperation with HCV core protein, B23, and YY1, and is dependent to a large extent on the presence of HCV core protein (Figure 9 , compare lanes 15 and 16). Thus, the recruitment of p300 to YY1 response element on B23 promoter is a specific effect exerted by the core protein (Figure 7 , lane 17), and this is through an interaction with HCV core, but not with YY1. However, it is also possible that HCV core may induce a conformational change in YY1 that alters the binding characteristic of YY1, and this results in the recruitment of p300 and B23.
Biological relevance of the complex formation between HCV core, B23, and YY1 It has been reported that the N-terminus half segment of B23 is important for its oligomerization and molecular chaperone activities, while the central segment of B23 molecule is essential for its ribonuclease activity and the C-terminal 76 amino-acid residues of B23 are critical for nucleic acid binding (Hingorani et al., 2000) . Since in this work we demonstrate that the C-terminal 9 amino acids of B23 are critical for its interaction with HCV core, while the central amino-acid residue 128-144 is essential for its interaction with YY1 (Figure 4c ), presumably the interactions between HCV core and B23 or YY1 and B23 do not disrupt the oligomerization properties of B23. In this regard, the results from the sucrose gradient analysis support this notion (Figure 3a) , because with or without HCV core at least half population of B23 in the gradient is present as a hexameric form with a molecular mass of 230-255 kDa (Yung and Chan, 1987) . Moreover, since HCV core and YY1 interact with different segments of B23, B23 may serve as a bridge or scaffold that mediates ternary complex formation. Furthermore, if we consider that both HCV core and B23 possess oligomerization activities and that HCV core, B23, and YY1 form a large complex with a size larger than 700 kDa (Figure 3a , fractions 14-16), the HCV core and B23 in this YY1-containing complex are possibly in an oligomeric form and other additional cellular components (e.g. p300) may also be present. It should also be noted that since the interacting regions of HCV core with B23 and YY1 with B23 overlap the regions critical for nucleic acid binding or ribonuclease activity of B23, presumably complex formation by either molecule might affect these two properties of B23.
According to previous studies, B23 is also involved in transcriptional regulation through interaction with YY1 (Inouye and Seto, 1994) , IRF-1 (Kondo et al., 1997) , p53 (Colombo et al., 2002) , or NFkB (Dhar et al., 2004) . Most interestingly, in this study we found that B23 also takes part in the control of its own gene expression mediated by cooperation with HCV core, YY1, and p300 ( Figure 9 ). When considering that the B23-interacting domains on YY1 molecule are located in the central GA/GK-rich domain and C-terminal zinc finger domain of YY1 and both are the trans-repression domains of YY1, this implies that B23 may relieve the trans-repression effect of YY1 through masking the trans-repression domains. However, in our assay systems, relief of the YY1 suppression effect by B23 on YY1 response element-containing promoters was not observed (Figure 6b and c, lane 7) , which contrasts with a previous report (Inouye and Seto, 1994) . There are certain clues that may explain this. First, although in vitro and in vivo studies support the physical interaction between B23 and YY1 (Figures 3 and 4) , both streptavidin-biotin agarose affinity chromatography and ChIP experiments reveal that B23 does not form a complex with YY1 on YY1 response element (Figure 5a and b, lane 2; Figure 7 , lane 6). Additionally, when HCV core is present, B23 forms a complex with HCV core and YY1 on YY1 response element (Figure 5a and b, lane 4; Figure 7 , lane 15). Based on these observations, it appears that HCV core has the ability to alter YY1's interaction partner.
B23 is capable of shuttling between the nucleus and cytoplasm and binding with a nuclear localization signal (NLS)-containing peptide (reviewed in Okuda, 2002) . Several studies indicate that HCV core protein localizes predominantly in the cytoplasm, but also in the nuclear granules to a lesser extent (Barba et al., 1997; Chen et al., 2003) . We found that B23 and HCV core colocalize in the nucleolus (Figure 2b) . Interestingly, amino-acid residues 51-100 of the HCV core, which harbors a functional bipartite NLS (Chen et al., 2003) , is essential for its interaction with B23 (Figure 2d ). In viewing of this, B23 may interact with this bipartite NLS of HCV core and transport HCV core into the nucleolus. Our previous work has also indicated that HCV core interacts with TBP and this interaction is required for the activation of RNA polymerase I transcription (Kao et al., 2004b) . Conceivably, HCV core may be transported into the nucleolus by interacting with B23, where it activates RNA polymerase I transcription and this may result in higher rate of ribosome biogenesis. When considering that ribosome biogenesis is well regulated and tightly linked to cell cycle progression (Moss and Stefanovsky, 2002) , these findings support an active role for HCV core protein in promoting cell growth and proliferation during the HCV infection. p300 is a coactivator for HCV core-mediated upregulation of B23 promoter In this work, we found that p300 but not CBP interacts with HCV core through an in vitro pull-down assay (Figure 8a ) and in vivo coimmunoprecipitation experiment (Figure 8b ). These results differ to some degree from those obtained by Gomez-Gonzalo et al. (2004) . In their work, they used CBP truncation mutants but not a full-length one for in vitro pulldown studies and concludes that HCV core interacts with the HAT domain of both p300 and CBP. Judging from our ChIP results which indicate that in the presence of HCV core, p300 but not CBP was recruited to the YY1 response element of B23 promoter (Figure 7 , lanes 17 and 18), it is likely that HCV core has a higher affinity for or specificity of interaction with p300. Moreover, when considering that the HAT domain is the highest homology region between the p300 and CBP molecules, presumably HCV core interacts with HAT domain but not the full-length version of CBP. This is consistent with earlier findings that, although p300 and CBP are generally believed to be transcriptional coactivators during transcriptional regulation (reviewed in Chan and La Thangue, 2001) , they cannot replace each other and function differently under at least some conditions (reviewed in Kalkhoven, 2004) . For example, p53 interacts with p300 but not CBP and this interaction is responsible for p53 transactivation function and the p53-mediated apoptotic response (Yuan et al., 1999) . Thus, as with the case of p53, HCV core interacts specifically with p300 and this interaction has functional relevance at least in the HCV core-mediated upregulation of the B23 promoter. p300 is a transcriptional coactivator with intrinsic HAT activity, which participates in alteration of chromatin structure and control of gene expression. The HAT enzymatic activity of p300 is essential for activation of several promoters including those of the IL-6 gene (Vanden Berghe et al., 1999) , the angiotensinogen gene (Ray et al., 2002) , and the IL-12 gene (Sun et al., 2004) . However, in some cases, such as enhancer A of the MHC class I gene (Brockmann et al., 2001 ) and the g globin gene (Song et al., 2002) , HAT activity of p300 is dispensable for promoter activation. In these cases, p300 serves as a scaffold and recruits other proteins that harbor HAT activity, like p300 and CBP associated factor (PCAF), which are able to activate promoters. In this work, we found that the HAT activity-deficient mutant of p300 (D1399Y) fails to activate B23 promoter and it also loses the synergistic effect exerted by cooperation with HCV core, YY1, and B23 (see Supplementary Figure 4) . Thus, the intrinsic HAT activity of p300 is critical for the upregulation of B23 promoter activity. Furthermore, since HCV core enhances the HAT activity of p300 (Gomez-Gonzalo et al., 2004) , the core-mediated enhancement of this enzymatic activity may also contribute to the activation of the B23 promoter.
Roles of HCV core in HCV-associated pathogenesis HCV core has been shown to be the major transforming agent among HCV viral products (reviewed in Watashi and Shimotohno, 2003) . Recently, HCV core has been reported to activate inducible nitric oxide synthase (iNOS) promoter and enhance DNA damage and mutation of cellular genes (Machida et al., 2004a, b) . Notably, overexpression of B23 often correlates with cellular proliferation and transformation (reviewed in Okuda, 2002) . Thus, the fact that HCV core enhances DNA mutation frequency (Machida et al., 2004a, b) , together with the finding that HCV core upregulates B23 gene expression as reported in this work, may partially account for the role of HCV core in cellular transformation.
HCV core protein has the ability to interact with various transcriptional regulators, such as hnRNP K, DEAD box RNA helicase (CAP-Rf), p53, LZIP, RXRa, Sp110b, Smad3, and TBP (Cheng et al., 2004; Kao et al., 2004a, b; and reviewed in Lai and Ware, 2000; Watashi and Shimotohno, 2003) , and is able to regulate the promoter activity of cellular or unrelated viral genes (reviewed in McLauchlan, 2000; Ray and Ray, 2001) . In this work, our finding of a targeted association of a multifunctional transcription factor YY1 with HCV core, and transcriptional coactivator p300 or B23 with HCV core, provides functional regulations for these transcriptional regulators, through which HCV core gains control over multiple transcriptional regulatory pathways in the host cells. Furthermore, since B23, YY1, and p300 have a multitude of cellular interacting proteins and are involved in a versatility of cellular processes, their interaction with core protein may impart on HCV a capability of regulating the function of their interacting partner as well. All these features of HCV core protein may at least partially account for its pleiotropic effects on gene expression and also its role in establishing the proliferation status of HCV-infected cells.
Materials and methods
Plasmids
Plasmid pSRa/HCVc195 is a mammalian expression construct for HCV core protein (You et al., 1999) . Plasmid pcDNASRa-FLAG-core, a mammalian expression construct for FLAG-tagged HCV core, was constructed by insertion of an EcoRI/XbaI-treated full-length HCV core fragment derived from PCR amplification into EcoRI/XbaI-digested pcDNASRa-FLAG. To obtain pcDNA-SRa-FLAG vector, pcDNA3-FLAG vector (Invitrogen) was treated with HindIII and NruI to eliminate the CMV promoter fragment, followed by Klenow fill-in, and then replaced with a 0.8 kb of ClaI-treated and Klenow filled-in SRa promoter fragment from pSRa vector (Takebe et al., 1988) . Plasmids pGST/HCVc50, pGST/ HCVc101, pGST/HCVc122, and pGST/HCVc195 had been described elsewhere (Shih et al., 1995; Chen et al., 2003) . Plasmid pET23a/HCVc was used as the DNA template to generate various lengths of T7-tagged in vitro translated HCV core (C101, C122, and C195) (Chen et al., 1997) . Plasmid pCR3-FLAG-B23 is the expression construct for FLAGtagged B23 in mammalian cells and also can serve as a DNA template for in vitro translation of the B23 protein and its variants (Huang et al., 2001) . Plasmid pGEX-T7 is a bacterial expression construct for the GST-B23 fusion protein (Huang et al., 2001) . Plasmid pRSETB-YY1 (kindly provided by Dr Y-M Lee, Academic Sinica, Taiwan) contains the full-length cDNA of YY1, which can serve as the DNA template for in vitro translation of YY1. Plasmid pGST-YY1 was constructed by insertion of an excised NcoI (filled in)/EcoRI DNA fragment harboring YY1 cDNA from pRSETB-YY1 into SmaI/EcoRI digested pGEX-2TKS (kindly provided by Dr S-J Lo, Chang-Gung University, Taiwan), which is a derivative of pGEX-2T containing additional KpnI and SacI cloning sites between the SmaI and EcoRI sites of the polylinker region. The pGST-YY1 serial deletion constructs pGST-YY1/1-80, pGST-YY1/1-154, pGST-YY1/1-198, pGST-YY1/1-295, pGST-YY1/1-325, pGST-YY1/1-352, pGST-YY1/155-198, pGST-YY1/199-295, and pGST-YY1/296-414 were constructed by insertion of a PCR-generated BamHI/SacI fragment of the indicated YY1 coding region into BamHI/ SacI digested pGEX-2TKS. Plasmid pGAL4-YY1 was generated by insertion of an excised BamHI/EcoRI fragment of YY1 cDNA derived from pGST-YY1 into BamHI/EcoRIdigested pFA-CMV (Stratagene). Plasmid pTK(À105B þ 51)-Luc, which contains a luciferase gene directed by a TK promoter (nt À105 to þ 51 in relation to the transcription start site) of Herpes simplex virus type 1, was constructed by insertion of a PCR-amplified XhoI/HindIII DNA fragment into XhoI/HindIII-digested pGL2-Basic (Promega). Plasmid pYY1-RE-Luc was generated by blunted-end insertion of two copies of annealed YY1 consensus binding elements (5 0 -CGCTCCGCGGCCATCTTGGCGGCTGGT-3 0 ) into SmaIdigested pTK(À105B þ 51)-Luc. Plasmid pB23P-Luc was constructed by insertion of a PCR-amplified XhoI/HindIII fragment of the B23 promoter (nt À744 to þ 35, related to the transcription start site) into XhoI/HindIII-digested pGL2-Basic (Promega). Reporter plasmid pB23Pmt-Luc, a derivative of pB23P-Luc harboring a mutation in YY1 response element on the B23 promoter, was generated by QuickChange s XL site-directed mutagenesis kit (Stratagene) according to the user manual. The complementary primers used to mutate the YY1 response element in the B23 promoter were: 5 0 -CTAAGGG CTGCCGACGAAGTTTTGCAGGGTGGGC-3 0 and 5 0 -GCCC ACCCTGCAAAACTTCGTCGGCAGCCCTTAG-3 0 . Plasmids pSK-p300-myc and pSK-p300D1399Y-myc were kindly provided by Dr T-P Yao (Ito et al., 2001) . Plasmids pGST-HDAC1, pGST-HDAC2, and pGST-HDAC3 are bacterial expression constructs that encode HDAC1, HDAC2, and HDAC3 fused with the C-terminus of GST, respectively (kindly provided by Dr J-L Juan, NHRI, Taiwan).
Cell cultures and subcellular fractionation
HuH-7 cells were cultured as described previously (Chen et al., 1997) . HuH-7/C190, also designated as the HuH-7/C190 pool, is a permanent cell line constitutively expressing the full-length of HCV core protein (Hsieh et al., 1995; Chen et al., 1997) . HuH-7/C190 #6 and HuH-7/C190 #3 are also permanent HCV core protein-producing cell lines expressing core protein with relative low and high levels, respectively, as compared to that of the HuH-7/C190 pool (see Figure 1b ; kindly provided by Dr L-H Hwang, National Taiwan University, Taiwan). The whole cell lysates or nuclear extracts were prepared as described previously (You et al., 1999) .
RNA preparation, mRNA differential display, reverse transcription, and quantitative real-time PCR The extraction of total cellular RNA and mRNA differential display was conducted as described previously (Huang et al., 2001) . DNase I-treated total RNA (2 mg) was reverse transcribed with reverse transcriptase M-MLV (Invitrogen) at 371C for 90 min. cDNA synthesis was primed with oligo(dT) 18 . The B23 cDNA was amplified with the primers 5 0 -AATTACGAAGGCAGTCCA-3 0 and 5 0 -AGACCGCTTT CCAGAT-3 0 . Internal control GAPDH cDNA was amplified with the primers 5 0 -GTCGGAGTCAACGGAT-3 0 and 5 0 -AG CTTCCCGTTCTCAG-3 0 . Quantitative real-time PCR was performed on LightCycler system with LightCycler FastStart DNA Master PLUS SYBR Green I (Roche). The PCR amplification conditions were as follows: 951C, 7 min; (951C, 10 s; 611C, 5 s; 721C, 10 s) Â 40 cycles. Relative quantitative evaluation of B23 RNA values was normalized to that of GAPDH and corrected to calibrator using the RelQuant software (Roche).
In vivo coimmunoprecipitation
The nuclear fractions (500 mg) prepared from HuH-7, HuH-7/ C190, or sucrose gradient fractions were immunoprecipitated with 20 ml of anti-FLAG M2 agarose affinity gel (Sigma) or protein G-Sepharose (Amersham Biosciences)-conjugated goat anti-B23 (C-19, Santa Cruz), rabbit anti-YY1 (C-20, Santa Cruz), or rabbit anti-p300 antibodies (C-20, Santa Cruz). After extensive washing with the NETN buffer (150 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH7.5, 0.5% Nonidet P-40), the proteins bound on the beads were eluted with sampling buffer, fractionated by SDS-PAGE (12% gel) and proceeded for Western blotting analysis with goat anti-B23, rabbit anti-HCV core (Shih et al., 1993) , or mouse anti-p300 antibodies (Upstate) using the enhanced chemiluminescence detection method (ECL, Pierce).
In vitro binding analysis HCV core protein, B23, YY1, or HDACs expressed as GST fusion proteins from the expression construct pGST/HCVc50, pGST/HCVc101, pGST/HCVc122, pGST/HCVc195, pGEX-T7, pGST-YY1 as well as various truncation mutants of pGST-YY1, pGST-HDAC1, pGST-HDAC2, and pGST-HDAC3 were purified as described previously (Shih et al., 1993) . For each in vitro binding assay, 20B30 ml of glutathione-Sepharose 4B beads (Amersham Biosciences) containing GST fusion proteins (4 mg) were incubated with cell extracts (500 mg), nuclear extracts (500 mg), or in vitro translated protein (5 ml) in binding buffer (PBS with protease inhibitor cocktail) overnight at 41C. The beads were washed four times with 1 ml of washing buffer (PBS containing 0.5% NP-40). Proteins bound on the beads were eluted by sampling buffer, fractionated by SDS-PAGE and processed for Western blot analysis with antibodies against HCV core, YY1, B23, p300 (Upstate), and CBP (C-20, Santa Cruz) or autoradiography.
Confocal microscopy
HuH-7 and HuH-7/C190 cells were seeded on glass coverslips. After 48 h, cells were fixed with acetone/methanol solution (1:1; À201C) for 5 min, and then reacted with primary and second antibodies as described (Kao et al., 2004a) . The cells were observed by laser-scanning confocal microscopy (Leica).
Sucrose gradient centrifugation
Sucrose gradient centrifugation was performed essentially as described previously (Huang et al., 2001 ). The nuclear extracts (500 mg in 0.4 ml) of HuH-7 and HuH-7/C190 were prepared for this assay. After centrifugation, aliquots of each fraction were detected for B23, YY1, or HCV core by immunoblotting.
Purification of the protein complexes bound on the YY1 response element The 5 0 biotinylated probe of YY1 consensus response element with a WT (5 0 -CGCTCCGCGGCCATCTTGGCGGCTGGT-3 0 ) or a mutant sequence (5 0 -CGCTCCGCGATTATCTTGGCGGC TGGT-3 0 ) were annealed with their complementary oligonucleotides in 50 ml of annealing buffer (40 mM Tris-HCl, pH 7.5, 20 mM MgCl 2 , 50mM NaCl) at 701C for 5 min. Nuclear extracts (100 mg) were precleared with 10 ml of streptavidinagarose beads (GibcoBRL) by incubation in 300 ml of binding buffer (18 mM HEPES, pH 7.9, 40 mM KCl, 2 mM MgCl 2 , 10 mM DTT, and protease inhibitor cocktail) at 41C for 30 min. The precleared nuclear extracts were incubated with 125 mg/ml poly(dI.dC) (Amersham Biosciences) at 41C for 30 min and then added to 12 ml of annealed WT or mutant form of biotinylated YY1 probe (20 mM), and 20 ml of 50% streptavidin-agarose beads. After incubation at room temperature for 1 h, the resins were washed five times with 1 ml of binding buffer. The bound fractions were eluted by sampling buffer, and analysed by SDS-PAGE, followed by immunoblotting.
Assay of reporter plasmid activity
HuH-7 cells (2 Â 10 5 cells/well) were seeded on a six-well plate and grown in 5% CO 2 at 371C for 20 h before transfection by the calcium phosphate coprecipitation method (Shih et al., 1993) or Lipofectamine Plust reagent (GibcoBRL). At 48 h posttransfection, the transfected cells were collected, and the luciferase activity of the cell lysates was assayed as described previously (You et al., 1999) .
ChIP assay
ChIP assay was performed as described previously with some modifications (Weinmann et al., 2001) . About 10 7 of HuH-7 or HuH-7/C190 cells for each ChIP reaction were fixed with 1% formaldehyde, lysed with 50 ml of lysis buffer, and sonicated three times using 10-s pulses with 20-s pauses each in a microtip ultrasonicator. After centrifugation, the nuclear lysates were diluted five fold with IP dilution buffer, precleared with 20 ml of protein G-Sepharose beads, and then incubated with specific antibodies overnight at 41C. The immunocomplexes were incubated with 20 ml of protein G-Sepharose beads, washed extensively, eluted with elution buffer, and then reversed the formaldehyde crosslinking. The DNA fragments were extracted using a Qiaquick s PCR purification Kit (Qiagen), and then analysed with 25-35 cycles of PCR with B23 promoter-specific primers (forward primer, 5 0 -TTCCTG AAGTGATTACGCC-3 0 ; reverse primer, 5 0 -CGTGCTTTCC AGTCGTAAC-3 0 ), which will amplify B23 promoter sequence containing the YY1-binding element. PCR products (250 bp in size) were run on a 1.8% agarose gel and analysed by ethidium bromide staining. R Kirby for critical reading and comments on this manuscript.
